New application of sulfadiazine sodium in preparing medicine for preventing or treating Bombyx mori septicemia
The invention discloses an application of sulfadiazine sodium in medicines for preventing or treating silkworm bacillus prodigiosus septicemia caused by bacteria. The medicine solution, in which the concentration of sulfadiazine sodium is 200-500 mg/L, has favorable effect on preventing and treating...
Gespeichert in:
Hauptverfasser: | , , , , , , |
---|---|
Format: | Patent |
Sprache: | chi ; eng |
Schlagworte: | |
Online-Zugang: | Volltext bestellen |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The invention discloses an application of sulfadiazine sodium in medicines for preventing or treating silkworm bacillus prodigiosus septicemia caused by bacteria. The medicine solution, in which the concentration of sulfadiazine sodium is 200-500 mg/L, has favorable effect on preventing and treating silkworm bacillus prodigiosus septicemia caused by the bacteria. The invention also discloses a composition capable of preventing and treating silkworm septicemia. The composition uses sulfadiazine sodium and enrofloxacin as the active ingredients, and also uses trimethoprim and auxiliary materials. The medicine composition can be used for simultaneously treating black-chest septicemia and bacillus prodigiosus septicemia of domestic silkworm. |
---|